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In cell culture. rabbit vascular smooth muscle cells were infected in a simi-
lar manner. Ii-Galactosidase staining was present at all 3 viral concentrations
but when a viral concentration of 1 x 1010 pfulml was used there were areas
of cellular necrosis not seen at the lower viral concentrations,
Conclusion: Replication-deficient adenovirus vectors can rapidly and effi-
ciently infect rabbit carotid vessels. However at doses often employed for
gene transfer experiments in-vivo, there is a dose dependent alteration of
vessel vasomotor function which may be mediated by a cytotoxic affect of
the viral vector, This effect needs to be taken into account in studies involving
adenoviral gene transfer.
Endothelin Immunoreactivity in Human
Coronary Atherosclerosis
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Monoclonal Antibody to Tissue Factor Inhibits
Intravascular Thrombosis without Impairing
Extravascular Hemostasis
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Coronary atherosclerosis and restenosis are disease processes involving cell
proliferation and activation of growth factors. Endothelin-l (ET-l). a vaso-
constrictor and mitogenic peptide, is produced from its precursor Big-ET.
Coronary plasma ET concentrations are elevated in coronary atherosclero-
sis and following coronary interventions. The current study was designed
to test the hypothesis that ET is produced and present in human coronary
atherosclerotic and restenotic lesions and localized to both endothelial and
nonendothelial cells. Twenty coronary lesions were obtained utilizing direc-
tional atherectomy. Immunohistochemistry for endothelins was performed
with rabbit polyclonal ET-l and Big-ET antiserum without cross reactivity be-
Background: Recent studies suggest that the release of tissue factor (TF) and
its interaction with factor VII at the site of vascular injury may be the activator
of the coagulation cascade, which along with platelet aggregation leads to
occlusive intravascular thrombus formation. We tested this hypothesis in a
rabbit carotid artery model of thrombosis.
Methods: Carotid artery was instrumented with Doppler flow probe and
a needle electrode. Partially occlusive thrombus was formed by applying
150 J.l.A of current which damages the endothelium of the carotid artery
and promotes thrombus formation. After development of 50% occlusion of
the artery by thrombus. the current was stopped and a murine monoclonal
antibody against rabbit TF (AP-l) (0.1 mglkg intraarterially) or vehicle (con-
trol) was administered. The changes in carotid blood flow were continuously
monitored by the Doppler flow probe. Bleeding was assessed by weigh-
ing the amount of blood absorbed in a preweighed sponge, placed in a cut
wound that was 5 cm long and 0.5 cm deep.
Results: The control rabbits (n = 12) occluded their arteries in 46.2 ± 13.6
min after stopping the current by a fibrin-platelet thrombus. In contrast, AP-l
prevented carotid artery occlusion for >200 min (n = 6) (p > 0.0001). Lower
doses of AP-l were ineffective. The deep incisional bleeding times were not
different between the control animals and the treated group, Similarly the
platelet counts or ex vivo platelet aggregation response to collagen, ADP
or arachidoic acid were not different between the control and the treated
animals.
Conclusion: Data suggest that TF released at the site of vascular injury
plays a role in intravascular coagulation and its activity can be selectively
inhibited, without inducing an alteration in hemostatic parameters or platelet
functions.
normal (non-cholesterol and non-treated) rabbits were evaluated as well. The
vasoreactive response to acetylcholine, serotonin and nitroprusside were
calculated from flow velocity measured by Doppler wire, vessel diameter
obtained from angiograms. and intra-arterial blood pressure recorded at
the proximal external iliac artery. The resistance response to endothelium-
dependent and -independent agonists recovered in VEGF group, as illus-
trated below. Furthermore, average intimal thickness of external iliac artery
and lower abdominal aorta in VEGF group was significantly less than control
group (VEGF = 0.010 ± 0.008 vs control = 0,106 ± 0.036, P < 0,05). Con-
clusion: Intermittent systemic administration of VEGF improves endothelial
dysfunction and attenuates intimal thickness in hypercholesterolemic rabbit.
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Gene transfer technologies offer great potential both to investigate and alter
the course of vessel wall pathophysiology. Replication-deficient adenovirus
vectors appear particularly useful for the transfection of blood vessels, be-
cause. of their ability to accommodate large cDNA inserts and to rapidly and
efficiently infect mammalian cells. However, the potential effects of transfec-
tion with a replication-deficient adenovirus on vasomotor function have not
been previously described. We performed gene transfer experiments with
a replication-deficient adenovirus which contained a cytomegalovirus pro-
moter and a nuclear-localizing variant of the bacterial Ii-galactosidase gene.
Excised carotid artery segments from 6 rabbits were divided into multiple
segments and infected in pairs. for 30 minutes with four different viral titers
(0,2,5 x 109.5 x 109, 1 x 1010 pfu/ml) at 3rC in serum free media. These
segments were tested for Ii-galactosidase staining and vasomotor function
2 days later. Isometric tension studies were performed to examine the re-
sponse of the vessel segments to the contractile agonist. norepinephrine
(NE). The results are shown below as mean ± standard error. -log lO lEC501
with * p :::: 0.04 between the lowest and the highest group.
embryonic kidney epithelial cells which are competent to replicate these
adenoviral vectors (293 cells). The vector incorporating the SMA promoter
demonstrated substantial selectivity for vascular smooth muscle gene ex-
pression. with typical transductions carried out in parallel under identical
conditions manifesting 90-95% lacZ-expressing BASMC. 0.3% lacZ-positive
A549 cells. and 4% positive 293 cells. Conversely, parallel transductions with
the vector employing the RSV promoter typically resulted in 95-99% lacZ-
expressing 293 cells at vector concentrations yielding only 5-10% positive
BASMC. These data support cell lineage-specificity of AvLacZ5 at the level of
promoter function rather than due to intrinsic cellular differences in capacity
for adenovirally-mediated transduction. However, it is notable that a limited
subpopulation of 293 cells clearly are able to direct sufficient transcription
from the SMA promoter sequences chosen to yield detectable lacZ expres-
sion; the molecular basis for this heterogeneity of expression remains to be
determined. Adenoviral vectors utilizing these promoter sequences may ren-
der vascular-restricted gene transfer feasible when used in conjunction with
mechanical devices providing a component of spatial localization.
Endothelial dysfunction in hypercholesterolemia causes abnormal arterial va-
soreactivity and precedes the onset of atherosclerosis, Vascular endothelial
growth factor (VEGF) is an endothelial cell (Ee) specific mitogen that has
been shown to stimulate EC proliferation in vitro and in vivo. We investi-
gated the hypothesis that VEGF could also modulate EC dysfunction and
thereby improve endothelium-dependent vasoreactivity. impaired due to hy-
percholesterolemia. Hypercholesterolemic rabbits fed a 1% cholesterol diet
for 6 weeks were treated with intravenous administration of 300 J.l.g VEGF
(VEGF group; n ~ 8) or 0.9% saline solution (control group; n = 91 twice
a week for 3 weeks, during which time both groups continued to receive
cholesterol diet. All rabbits were evaluated by in vivo vasomotion study; 8
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tween Big-ET and ET-1 antisera. In addition, staining for specific cell types,
including macrophages (KP-1). endothelial cells (Factor VIII), and myointimal
cells (actin). was performed. Eight primary native lesions, six restenotic le-
sions, and six vein graft (VG) lesions were studied. In all lesion types, in-
tracellular Big-ET and ET-1 were present and in the extracellular matrix and
colocalized to area with endothelial cells, macrophages, fibroblasts, and my-
ointimal cells. ET-1 and Big-ET were colocalized to area with myointimal cells
only in the primary native lesions. This study demonstrates the presence of
Big-ET and ET-1 in coronary and VG atherosclerotic and restenotic lesions.
This study suggests that ET is produced locally in the atherosclerotic and
restenotic lesions by endothelial and nonendothelial cells. ET may playa role
in the changes in tissue architecture and pathogenesis of coronary and VG
atherosclerosis and restenosis.
Conclusions: SMC cultures derived from human coronary samples ob-
tained by DCA express MCP-' during their quiescent phase, and this expres-
sion is markedly increased by the cytokines POGF, IGF-1 and TNF•. Thus by
attracting monocytes to the area of vascular injury, MCP-1 may be intimately
involved in coronary restenosis, playing an important role in the pathophysi-
ology of this process\1012-106\ The Genotype of the ACE Gene and CollateralFormation
Con PDGF IGF·1 TNFa
Control
PDGF
IGF-1
TNFa
100.0%
121.4%
130.3%
219.1%
Thus, presence of collateral circuletion was more frequent in subjects with
II genotype. This study suggests that the ACE genotype may influence left
ventricular function after MI through affecting collateral formation.
Peripheral Vascular Disease - Thrombosis
Risk Group By Clinical Evaluation
Postoperative and Late Prognosis for Diabetics
Undergoing Vascular Surgery: Combining
Clinical Evaluation and Dipyridamole-Thallium
Imaging Improves Risk Stratification
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Prior studies suggest that pts with diabetes mellitus (OM) have a poor prog-
nosis after vascular surgery and do not benefit from preoperative risk strati-
fication by clinical evaluation or dipyridamole-thallium (DT) imaging because
of a high prevalence of underlying coronary artery disease. To determine the
postop and late prognosis for diabetics undergoing vascular surgery and the
utility of clinical evaluation and OT for stratifying risk; we studied 122 pts
with OM who underwent clinical evaluation and OT prior to vascular surgery.
Based on the number of clinical markers present (using a previously de-
scribed clinical risk index: prior MI, angina, Q wave on ECG, age> 70 yrs,
CHF); pts were classified into low (0). intermediate (1-2). and high risk (>2
markers) for postop and late cardiac events. OT was assessed for reversible
(REV) and fixed defects. There were 17 (14%) pts with postop events (4
cardiac deaths, 13 non-fatal Mis), and 23 (22%) with late events (8 cardiac
deaths, 15 non-fatal Mis) on follow up which was possible in 98% of pts and
was to 50 ± 5 months (75th quintile). On multivariate analysis, the only pre-
dictorfor postop event was REV (p < 0.01) in this inherently high risk cohort.
Successful risk stratification for late events was achieved by clinical index.
OT was not of prognostic value for late event.
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Conclusions: (') Although diabetics are at high risk for events,
dipyridamole-thallium imaging provides additional useful perioperative risk
stratification. (2) The absence of clinical markers identifies a group with sig-
nificantly better late cardiac event-free survival.
Dipyridamole Rb-82 Positron Emission
Tomography Has Limitations for Predicting
Cardiac Events Peri- and Post·Operatively after
Vascular Surgery
Kesavan Shan, Thomas Marwick, Raymundo Go, William Macintyre,
Donald Underwood, James Thomas. Cleveland Clinic Foundation, Cleveland, OH
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Thallium imoying has been used to risk-stratify pts undergoing vascular
surgery (VS), though the efficacy of this approach is debated. Positron emis-
sion tomography (PET) has the benefit of permitting a true resting scan, mea-
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Monocyte Chemotactic Protein-1 Expression in
Smooth Muscle Cell Cultures Derived from
Human Coronary Arteries
EF 1st
EF 2nd
Collaterall +1-)
10 + DO In = 91) II In = 67) P
FemalelMale 19/72 15/52 0820
AP/OMI 21{l0 23/44 0119
RCA + Cx/LAO 37/54 34/33 0208
TIMI(Q-2/31 51/40 38/29 0.932
Collateral( +1-1 28/63 36/31 0.003
EF 2nd in subjects with either 10 or DO genotype was significantly lower
than in subjects with II genotype. Interestingly, presence of collateral circu-
lation to infarct-related artery at the first CAG was more frequently observed
in sUbjects with II genotype. To confirm the latter, we analyzed all subjects
with ischemic heart disease who were performed CAG in our department in
1993.
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The DO genotype of the angiotensin converting enzyme (ACE) gene has been
reported to be a risk factor of myocardial infarction (MI). ischemic and id-
iopathic dilated cardiomyopathy, and left ventricular hypertrophy. The DO
genotype of the ACE gene is associated with higher plasma ACE level, and
thus may be associated with higher angiotensin II production in peripheral
tissues. Because intimate involvement of angiotensin II in ventricular remod-
eling after MI has been reported, the genotype of the ACE could influence
ventricular function after MI. The study population consisted of 66 subjects
of Ml who were performed twice coronary angiography (CAG) and left ven-
triculography(LVG). The first LVG was performed at 3.0 ± 2.9 months, and
the second was performed at 10.2 ± 9.9 months from the onset of MI.
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Peripheral blood monocytes and monocyte-derived macrophages are be-
lieved to playa pivotal role in the development of early atherosclerotic
lesions. Excessive smooth muscle cell (SMC) proliferation leads to coro-
nary restenosis after interventional procedures. We postulate that monocyte
chemotactic protein-1 (MCP-1). by attracting monocytes to the site of vas-
cular injury may indirectly augment this process. We also hypothesize that
MCP-1 expression by human SMC may be mediated bycytokines and growth
factors. Accordingly, we studied SMC cultures derived from tissue obtained
by directional coronary atherectomy, evaluating MCP-1 expression by North-
ern blot analysis. Cells were grow in M-199 medium to over 95% confluence,
for the last 24 hrs in serumless medium. MCP-' expression was assessed in
unstimulated (control) cells, and after 6 hrs stimulation with platelet derived
growth factor (POGF). insulin-like growth factor-1 (IGF-1) and tumor necrosis
factor alpha (TNF.). Autoradiographs were developed, scanned and digitized
using NIH 1.53b10 software. Our findings suggest that unstimulated human
coronary SMC derived cultures express MCP-1 and furthermore this expres-
sion is markedly increased after stimulation with cytokines (by 21.4% after
stimulation with POGF, 30.3% after IGF-1 and 119.1 % after TNF.).
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